This study will evaluate imaging characteristics of 18F-AV-1451 in subjects with subacute traumatic brain injury.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
NIH Clinical Center
Bethesda, Maryland, United States
TBI Biomarker Analysis
18F-AV-1451 uptake will be compared in subjects with TBI and controls.
Time frame: 75-105 minutes postinjection
Relationship Between Clinical Presentation and Tau Deposition (MMSE)
The relationship between 18F-AV-1451 uptake and clinical measures using Mini-Mental State Examination (MMSE).
Time frame: 75-105 minutes postinjection
Change in tau deposition over time
Assess the rate of change of tau deposition as measured by 18F-AV-1451 uptake over time.
Time frame: 6 months
Relationship Between Clinical Presentation and Tau Deposition (BIS-11)
The relationship between 18F-AV-1451 uptake and clinical measures using Barratt Impulsivity Scale 11 (BIS-11)
Time frame: 75-105 minutes postinjection
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.